SIKE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.747800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.385400E-01
Normal-vs-Stage2
3.272400E-01
Normal-vs-Stage3
5.458400E-02
Normal-vs-Stage4
9.854600E-01
Stage1-vs-Stage2
8.724800E-01
Stage1-vs-Stage3
2.202200E-01
Stage1-vs-Stage4
3.501400E-01
Stage2-vs-Stage3
1.288750E-01
Stage2-vs-Stage4
2.504000E-01
Stage3-vs-Stage4
8.956100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.413800E-01
Normal-vs-AfricanAmerican
8.460200E-01
Normal-vs-Asian
4.274000E-01
Caucasian-vs-AfricanAmerican
2.214600E-01
Caucasian-vs-Asian
8.299800E-01
AfricanAmerican-vs-Asian
4.867800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.042000E-01
Normal-vs-Female
3.903800E-01
Male-vs-Female
1.944410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.179400E-01
Normal-vs-Age(41-60Yrs)
5.158800E-01
Normal-vs-Age(61-80Yrs)
2.318600E-01
Normal-vs-Age(81-100Yrs)
9.389900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.243600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.692600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.510200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.946350E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.182400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.682000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.262300E-02
Normal-vs-Daily Drinker
2.025000E-01
Normal-vs-Weekly Drinker
2.199600E-01
Normal-vs-Occasional Drinker
4.092800E-01
Normal-vs-Social Drinker
6.297000E-01
Non Drinker-vs-Daily Drinker
9.145800E-01
Non Drinker-vs-Weekly Drinker
8.326000E-01
Non Drinker-vs-Occasional Drinker
8.244500E-02
Non Drinker-vs-Social Drinker
4.637600E-02
Daily Drinker-vs-Weekly Drinker
9.263400E-01
Daily Drinker-vs-Occasional Drinker
1.864160E-01
Daily Drinker-vs-Social Drinker
1.220220E-01
Weekly Drinker-vs-Occasional Drinker
2.541600E-01
Weekly Drinker-vs-Social Drinker
1.778580E-01
Occasional Drinker-vs-Social Drinker
6.707400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.781400E-01
Normal-vs-Grade 2
7.571000E-01
Normal-vs-Grade 3
7.784400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.242620E-01
Grade 1-vs-Grade 3
2.227000E-01
Grade 1-vs-Grade 4
6.781400E-01
Grade 2-vs-Grade 3
6.530400E-01
Grade 2-vs-Grade 4
7.571000E-01
Grade 3-vs-Grade 4
7.784400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.239560E-01
Normal-vs-NonDiabetic
2.214800E-01
Diabetic-vs-NonDiabetic
4.006400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.388400E-01
Normal-vs-NoPancreatitis
1.925750E-01
Pancreatitis-vs-NoPancreatitis
5.831600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.253000E-01
Normal-vs-N1
3.183000E-01
N0-vs-N1
2.695800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.879400E-01
Normal-vs-TP53-NonMutant
3.833200E-01
TP53-Mutant-vs-TP53-NonMutant
7.417800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
